PUBLICATION

EHD2 modulates Dll4 endocytosis during blood vessel development

Authors
Webb, A.M., Francis, C.R., Judson, R.J., Kincross, H., Lundy, K.M., Westhoff, D.E., Meadows, S.M., Kushner, E.J.
ID
ZDB-PUB-211129-29
Date
2021
Source
Microcirculation (New York, N.Y. : 1994)   29(1): e12740 (Journal)
Registered Authors
Keywords
Angiogenesis, Delta-like 4 protein, EHD2, Notch, Zebrafish, blood vessel development, endocytosis, trafficking, transcytosis
MeSH Terms
none
PubMed
34820962 Full text @ Microcirculation
Abstract
Despite the absolute requirement of Delta/Notch signaling to activate lateral inhibition during early blood vessel development, many mechanisms remain unclear about how this system is regulated. Our objective was to determine the involvement of Epsin 15 Homology Domain Containing 2 (EHD2) in delta-like ligand 4 (Dll4) endocytosis during Notch activation.
Using both in vivo and in vitro models, we demonstrate that EHD2 is a novel modulator of Notch activation in endothelial cells through controlling endocytosis of Dll4. In vitro, EHD2 localized to plasma membrane bound Dll4 and caveolae. Chemical disruption of caveolae complexes resulted in EHD2 failing to organize around Dll4 as well as loss of Dll4 internalization. Reduced Dll4 internalization blunted Notch activation in endothelial cells. In vivo, EHD2 is primarily expressed in the vasculature, colocalizing with junctional marker VE-cadherin and Dll4. Knockout of EHD2 in zebrafish produced a significant increase in dysmorphic sprouts in zebrafish intersomitic vessels during development and a reduction in downstream Notch signaling.
Overall, we demonstrate that EHD2 is necessary for Dll4 transcytosis and downstream Notch activation.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping